Eli Lilly’s diabetes drug tirzepatide gained US approval for treating patients with obesity under a new name, Zepbound.
Home
United States
USA — mix FDA approves yet another weight loss drug to compete against blockbuster sellers...
FDA approves yet another weight loss drug to compete against blockbuster sellers Ozempic and Wegovy
